Certificate of Analysis
HPLC verified · Batch #65AE36
Tesamorelin
2mg SubQ daily
Tesamorelin is an FDA-approved GHRH (Growth Hormone Releasing Hormone) analog originally indicated for HIV-associated lipodystrophy. It is one of the most potent growth hormone secretagogues available, specifically targeting visceral adipose tissue reduction while supporting lean body mass and metabolic health markers.
Best Stacked With
Tesamorelin is an FDA-approved GHRH (Growth Hormone Releasing Hormone) analog originally indicated for HIV-associated lipodystrophy. It is one of the most potent growth hormone secretagogues available, specifically targeting visceral adipose tissue reduction while supporting lean body mass and metabolic health markers.
How It Works
Binds to pituitary GHRH receptors to stimulate endogenous GH production. Selectively reduces visceral adipose tissue through lipolytic pathways. Increases IGF-1 levels.
Primary Applications
Visceral fat loss, metabolic health, body composition
Important Information
This product requires a valid prescription from a licensed physician. Compounded peptides are prepared by licensed, FDA-registered compounding pharmacies under USP 797/795 standards. Compounded medications are not FDA-approved and have not been evaluated for safety, efficacy, or therapeutic equivalence. Individual results may vary. All peptide protocols require physician evaluation and ongoing medical supervision.
Tesamorelin
$189.00